ADMA Biologics (ADMA) Insider Trading & Ownership $21.18 -0.12 (-0.56%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$13.54 M Get ADMA Insider Trade Alerts Want to know when executives and insiders are buying or selling ADMA Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADMA Insider Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here ADMA Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/22/2024Brad L TadeCFOSell15,000$21.15$317,250.00 9/9/2024Lawrence P GuiheenDirectorSell9,000$18.47$166,230.00 8/30/2024Kaitlin M Kestenberg-MessinaCOOSell24,150$16.90$408,135.00 8/29/2024Jerrold B GrossmanDirectorSell136,861$17.27$2,363,589.47 8/26/2024Adam S GrossmanCEOSell236,889$17.69$4,190,566.41 8/23/2024Young KwonDirectorSell60,000$18.26$1,095,600.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/14/2024Adam S GrossmanCEOSell100,000$10.72$1,072,000.00 3/18/2024Steve ElmsDirectorSell49,887$6.01$299,820.87 3/15/2024Steve ElmsDirectorSell183,008$6.01$1,099,878.08 3/13/2024Steve ElmsDirectorSell407,000$6.21$2,527,470.00 (Data available from 1/1/2013 forward) ADMA Insider Trading Activity - Frequently Asked Questions Who is on ADMA Biologics's Insider Roster? The list of insiders at ADMA Biologics includes Adam S Grossman, Brad L Tade, Brian Lenz, Bryant Fong, Jerrold B Grossman, Kaitlin M Kestenberg-Messina, Lawrence P Guiheen, Steve Elms, and Young Kwon. Learn more on insiders at ADMA. What percentage of ADMA Biologics stock is owned by insiders? 3.70% of ADMA Biologics stock is owned by insiders. Learn more on ADMA's insider holdings. Which ADMA Biologics insiders have been buying company stock? The following insiders have purchased ADMA shares in the last 24 months: Adam S Grossman ($42,851.38), Brian Lenz ($19,999.98), Jerrold B Grossman ($482,300.00), and Young Kwon ($97,500.00). How much insider buying is happening at ADMA Biologics? Insiders have purchased a total of 176,976 ADMA shares in the last 24 months for a total of $642,651.36 bought. Which ADMA Biologics insiders have been selling company stock? The following insiders have sold ADMA shares in the last 24 months: Adam S Grossman ($8,617,595.67), Brad L Tade ($317,250.00), Brian Lenz ($973,258.80), Bryant Fong ($5,546,886.48), Jerrold B Grossman ($2,363,589.47), Kaitlin M Kestenberg-Messina ($408,135.00), Lawrence P Guiheen ($166,230.00), Steve Elms ($3,927,168.95), and Young Kwon ($1,095,600.00). How much insider selling is happening at ADMA Biologics? Insiders have sold a total of 3,627,146 ADMA Biologics shares in the last 24 months for a total of $23,415,714.37 sold. ADMA Biologics Key ExecutivesMr. Adam S. Grossman (Age 47)Co-Founder, President, CEO & Director Compensation: $1.59M2 recent tradesDr. Jerrold B. Grossman D.P.S. (Age 76)Ph.D., Co-Founder & Vice Chairman of the Board Compensation: $90kMs. Kaitlin Kestenberg (Age 37)COO & Senior VP of Compliance Mr. Drew PantelloVice President of Marketing & Corporate DevelopmentMs. Cindy PetersenExecutive Director of Human ResourcesMr. Skyler BloomSenior Director of Business Development & Corporate StrategyMr. Brad TadeVice President of Financial Operations1 recent trades More Insider Trading Tools from MarketBeat Related Companies SLDB Insider Selling LOGC Insider Selling CSBR Insider Selling TEVA Insider Selling BGNE Insider Selling VTRS Insider Selling MRNA Insider Selling SMMT Insider Selling GMAB Insider Selling PCVX Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ADMA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.